GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » PharmX Technologies Ltd (ASX:PHX) » Definitions » Debt-to-Asset

PharmX Technologies (ASX:PHX) Debt-to-Asset : 0.01 (As of Dec. 2023)


View and export this data going back to 1973. Start your Free Trial

What is PharmX Technologies Debt-to-Asset?

PharmX Technologies's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was A$0.10 Mil. PharmX Technologies's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was A$0.19 Mil. PharmX Technologies's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Dec. 2023 was A$29.60 Mil. PharmX Technologies's debt to asset for the quarter that ended in Dec. 2023 was 0.01.


PharmX Technologies Debt-to-Asset Historical Data

The historical data trend for PharmX Technologies's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmX Technologies Debt-to-Asset Chart

PharmX Technologies Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Debt-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 0.04 0.01 0.01 -

PharmX Technologies Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 0.01 0.01 - 0.01

Competitive Comparison of PharmX Technologies's Debt-to-Asset

For the Health Information Services subindustry, PharmX Technologies's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PharmX Technologies's Debt-to-Asset Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, PharmX Technologies's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where PharmX Technologies's Debt-to-Asset falls into.



PharmX Technologies Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

PharmX Technologies's Debt-to-Asset for the fiscal year that ended in Jun. 2023 is calculated as

PharmX Technologies's Debt-to-Asset for the quarter that ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PharmX Technologies  (ASX:PHX) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


PharmX Technologies Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of PharmX Technologies's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


PharmX Technologies (ASX:PHX) Business Description

Traded in Other Exchanges
N/A
Address
17 Castlereagh Street, Level 11, Sydney, NSW, AUS, 2000
PharmX Technologies Ltd Formerly Corum Group Ltd is an Australia-based software and technology company. The company has a single segment which is Health Services. In Health services, the company develops and distributes business software for the pharmacy industry with particular emphasis on point-of-sale and pharmaceutical dispensing software, support services, and associated computer hardware. It derives a majority of its revenue from the Health services business. the company discontinued the e-commerce business in 2022.